title: Hodgkin lymphoma.
authors.affiliation: Stanford Cancer Institute, USA.
authors.forename: Richard T
authors.initials: RT
authors.lastname: Hoppe
authors.forename: Ranjana H
authors.initials: RH
authors.lastname: Advani
authors.forename: Weiyun Z
authors.initials: WZ
authors.lastname: Ai
authors.forename: Richard F
authors.initials: RF
authors.lastname: Ambinder
authors.forename: Celeste M
authors.initials: CM
authors.lastname: Bello
authors.forename: Philip J
authors.initials: PJ
authors.lastname: Bierman
authors.forename: Kristie A
authors.initials: KA
authors.lastname: Blum
authors.forename: Bouthaina
authors.initials: B
authors.lastname: Dabaja
authors.forename: Ysabel
authors.initials: Y
authors.lastname: Duron
authors.forename: Andres
authors.initials: A
authors.lastname: Forero
authors.forename: Leo I
authors.initials: LI
authors.lastname: Gordon
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Hernandez-Ilizaliturri
authors.forename: Ephraim P
authors.initials: EP
authors.lastname: Hochberg
authors.forename: David G
authors.initials: DG
authors.lastname: Maloney
authors.forename: David
authors.initials: D
authors.lastname: Mansur
authors.forename: Peter M
authors.initials: PM
authors.lastname: Mauch
authors.forename: Monika
authors.initials: M
authors.lastname: Metzger
authors.forename: Joseph O
authors.initials: JO
authors.lastname: Moore
authors.forename: David
authors.initials: D
authors.lastname: Morgan
authors.forename: Craig H
authors.initials: CH
authors.lastname: Moskowitz
authors.forename: Matthew
authors.initials: M
authors.lastname: Poppe
authors.forename: Barbara
authors.initials: B
authors.lastname: Pro
authors.forename: Lawrence
authors.initials: L
authors.lastname: Weiss
authors.forename: Jane N
authors.initials: JN
authors.lastname: Winter
authors.forename: Joachim
authors.initials: J
authors.lastname: Yahalom
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D018450:Disease Progression; D006689:Hodgkin Disease / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D009367:Neoplasm Staging; D011379:Prognosis; D011878:Radiotherapy / Q000009:adverse effects; D012008:Recurrence; D057832:Watchful Waiting